Accelerating the implementation of New Approach Methodologies and other innovative non-animal approaches for the development, testing and production of health technologies
This EU funding program, HORIZON-JU-IHI-2023-05-01, is a closed call focused on accelerating the adoption of New Approach Methodologies (NAMs) and other innovative non-animal approaches in health technology development, testing, and production. It aims to reduce reliance on animal testing due to ethical concerns and scientific limitations, while enhancing the safety, efficacy, and efficiency of health technologies. The initiative seeks to foster collaboration among diverse stakeholders to drive this transition and strengthen Europe's position in innovative health solutions.
Who is Funded and Program Objectives
This section provides an overview of the entities eligible for funding under this program, specifying the types of applicants, the geographical scope of the projects, and the overarching objectives that the program aims to achieve.
What is Funded: Scope and Focus
This section details the types of projects and thematic areas that receive funding, including the eligible sectors, covered costs, and the developmental stages of projects supported by the program.
Type and Scope of Financial Support
This section provides information on the financial support mechanisms available through the program, detailing the type of financial instrument, the typical funding amounts, and any known duration of projects.
Conditions and Requirements for Applicants
This section outlines the essential rules, regulations, and specific conditions that applicants and beneficiaries must adhere to throughout the application and project implementation phases.
Application Procedure Details
This section outlines the process for submitting applications, from preparation to evaluation and decision notification.
Legal Basis and Governing Documents
This section identifies the fundamental legal and official documents that establish and govern the funding program, ensuring its legitimacy and guiding its operational framework.
Similar Programs
Funding Overview
Funding Status:
Closed
Maximum Amount:
15,000,000 €
Allocated Budget:
EUR 24,000,000 - 30,000,000 (for this topic); EUR 83,052,315 (total recommended for above-threshold proposals across the call)
Deadline:
16.01.2024
Open Until:
Ongoing
Award Channel:
Framework Programme Call
Region:
European Union and Associated Countries, with specific provisions for other non-EU/non-Associated Countries as per the Horizon Europe Programme Guide.
Sectors:
Healthcare, Pharmaceutical Industry, Medical Technology, Research and Development, Environmental and Climate Protection, Other
Beneficiaries:
Health technology developers, pharmaceutical industry, medical device industry, biotechnology industry, researchers, regulators, policy makers, patients
Application Type:
Consortium Required
Funding Stages:
Applied Research, Experimental Development, Prototyping, Pilot Testing, Product Development, Process Optimization
Funding Provider
Program Level:
European Union
Funding Body:
Innovative Health Initiative Joint Undertaking (IHI JU)
Managed By:
Innovative Health Initiative Joint Undertaking (IHI JU)
Additional Partners:
European Medicines Agency (EMA)
Website: